» Articles » PMID: 31696111

Mucins and Pathogenic Mucin-Like Molecules Are Immunomodulators During Infection and Targets for Diagnostics and Vaccines

Overview
Journal Front Chem
Specialty Chemistry
Date 2019 Nov 8
PMID 31696111
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Mucins and mucin-like molecules are highly O-glycosylated proteins present on the cell surface of mammals and other organisms. These glycoproteins are highly diverse in the apoprotein and glycan cores and play a central role in many biological processes and diseases. Mucins are the most abundant macromolecules in mucus and are responsible for its biochemical and biophysical properties. Mucin-like molecules cover various protozoan parasites, fungi and viruses. In humans, modifications in mucin glycosylation are associated with tumors in epithelial tissue. These modifications allow the distinction between normal and abnormal cell conditions and represent important targets for vaccine development against some cancers. Mucins and mucin-like molecules derived from pathogens are potential diagnostic markers and targets for therapeutic agents. In this review, we summarize the distribution, structure, role as immunomodulators, and the correlation of human mucins with diseases and perform a comparative analysis of mucins with mucin-like molecules present in human pathogens. Furthermore, we review the methods to produce pathogenic and human mucins using chemical synthesis and expression systems. Finally, we present applications of mucin-like molecules in diagnosis and prevention of relevant human diseases.

Citing Articles

Physiology and pathophysiology of mucus and mucolytic use in critically ill patients.

Roe T, Talbot T, Terrington I, Johal J, Kemp I, Saeed K Crit Care. 2025; 29(1):68.

PMID: 39920835 PMC: 11806889. DOI: 10.1186/s13054-025-05286-x.


Mucins as Precision Biomarkers in Glioma: Emerging Evidence for Their Potential in Biospecimen Analysis and Outcome Prediction.

Erickson A, Jackson L, Camphausen K, Krauze A Biomedicines. 2025; 12(12.

PMID: 39767713 PMC: 11673638. DOI: 10.3390/biomedicines12122806.


Sulfated Cellulose Nanofiber Hydrogel with Mucus-Like Activities for Virus Inhibition.

Long Y, Dimde M, Adler J, Vidal R, Povolotsky T, Nickl P ACS Appl Mater Interfaces. 2024; 16(49):67504-67513.

PMID: 39582136 PMC: 11647751. DOI: 10.1021/acsami.4c17998.


Pilot investigations into the mechanistic basis for adverse effects of glucocorticoids in dysferlinopathy.

Lloyd E, Crew R, Haynes V, White R, Mark P, Jackaman C Skelet Muscle. 2024; 14(1):19.

PMID: 39123261 PMC: 11312411. DOI: 10.1186/s13395-024-00350-6.


Changes in the Expression of Genes Regulating the Response to Hypoxia, Inflammation, Cell Cycle, Apoptosis, and Epithelial Barrier Functioning during Colitis-Associated Colorectal Cancer Depend on Individual Hypoxia Tolerance.

Dzhalilova D, Silina M, Tsvetkov I, Kosyreva A, Zolotova N, Gantsova E Int J Mol Sci. 2024; 25(14).

PMID: 39063041 PMC: 11276979. DOI: 10.3390/ijms25147801.


References
1.
Birchenough G, Johansson M, Gustafsson J, Bergstrom J, Hansson G . New developments in goblet cell mucus secretion and function. Mucosal Immunol. 2015; 8(4):712-9. PMC: 4631840. DOI: 10.1038/mi.2015.32. View

2.
Almeida I, Camargo M, Procopio D, Silva L, Mehlert A, Travassos L . Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 2000; 19(7):1476-85. PMC: 310217. DOI: 10.1093/emboj/19.7.1476. View

3.
Leir S, Harris A . MUC6 mucin expression inhibits tumor cell invasion. Exp Cell Res. 2011; 317(17):2408-19. DOI: 10.1016/j.yexcr.2011.07.021. View

4.
Varela O, de Lederkremer R . One-pot synthesis of beta-D-Galf(1-->4)[beta-D-Galp(1-->6)]-D-GlcNAc, a 'core' trisaccharide linked O-glycosidically in glycoproteins of Trypanosoma cruzi. Carbohydr Res. 1998; 305(2):163-70. DOI: 10.1016/s0008-6215(97)00256-5. View

5.
Kasprzak A, Adamek A . Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis. Int J Mol Sci. 2019; 20(6). PMC: 6471604. DOI: 10.3390/ijms20061288. View